|
FBXO21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.01479952113937E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.25670609871531E-12 |
| Normal-vs-Stage3 |
3.18519988162791E-10 |
| Normal-vs-Stage4 |
1.19330000003526E-06 |
| Stage1-vs-Stage2 |
2.873200E-01 |
| Stage1-vs-Stage3 |
1.771360E-01 |
| Stage1-vs-Stage4 |
9.731000E-01 |
| Stage2-vs-Stage3 |
4.684300E-02 |
| Stage2-vs-Stage4 |
5.430800E-01 |
| Stage3-vs-Stage4 |
3.877200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.11749498543645E-11 |
| Normal-vs-Asian |
1.20150001059471E-10 |
| Caucasian-vs-AfricanAmerican |
6.527400E-01 |
| Caucasian-vs-Asian |
4.162000E-02 |
| AfricanAmerican-vs-Asian |
1.750750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91670013194312E-11 |
| Normal-vs-Female |
1.73883130116792E-12 |
| Male-vs-Female |
1.650790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.84157158808785E-12 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
5.98020521991316E-11 |
| Normal-vs-Extreme_Obese |
7.27929938548755E-11 |
| Normal_Weight-vs-Extreme_Weight |
5.499600E-01 |
| Normal_Weight-vs-Obese |
6.347200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.710000E-01 |
| Extreme_Weight-vs-Obese |
1.675600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.206000E-01 |
| Obese-vs-Extreme_Obese |
8.129900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.18090040155539E-10 |
| Normal-vs-Age(41-60Yrs) |
6.69430066935206E-11 |
| Normal-vs-Age(61-80Yrs) |
6.41908748377773E-12 |
| Normal-vs-Age(81-100Yrs) |
4.42999970040603E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.105400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.531600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.783250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.591700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.957800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.993000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.2960965634079E-11 |
| Normal-VS-Type2 PRCC |
1.33226762955019E-15 |
| Normal-VS-KIRP CIMP |
8.33040000314256E-08 |
| Normal-VS-Unclassified PRCC |
2.23699947454747E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.109800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.454800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.068300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.435000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.066000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.307600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.85500528668581E-13 |
| Normal-vs-N1 |
2.2945999988977E-08 |
| Normal-vs-N2 |
1.236380E-03 |
| N0-vs-N1 |
6.718400E-03 |
| N0-vs-N2 |
6.147000E-01 |
| N1-vs-N2 |
4.568600E-01 |
|
|
